TEOSYAL ® DERMAL FILLER RAN TEOSYAL ® DERMAL FILLER
REDENSITY 1
RHA 1
RHA 2
R
REDENSITY 1
RHA 1
RHA 2
RHA 3
Hyaluronic acid concentration
Hyaluronic acid concentration
15 mg/mL
15 mg/mL
23 mg/mL
23 mg/mL 2
15 mg/mL
15 mg/mL
23 mg/mL
Non crosslinked HA + crosslinked HA +
Non crosslinked HA + crosslinked HA +
Crosslinked HA +
Crosslinked H + Cro
Non crosslinked HA + supplemented 1
Crosslinked HA +
Non crosslinked HA + supplemented 1
Composition
Composition
pH 7.3 1
pH 7.3 1
pH 7.3 1
pH 7.3 1
pH 7.3 1
Lidocaine
Lidocaine
0.3%
0.3%
0.3%
0.3%
0.3%
0.3%
0.3%
Supercial Dermis
Mid Dermis
Mid Dermis
Deep Dermal Deep
Supercial Dermis
Mid Dermis
Mid Dermis
Injection depth
Injection depth
Packaging
Packaging
1 x 3mL or 2 x 1mL
2 x 1mL
2 x 1mL
1 x 3mL or 2 x 1mL
2 x 1mL
2 x 1mL
2 x 1mL
Needle
Needle
27G x 1/2” 27
30G1/2” or 32G
30G x 1/2”
30G x 1/2”
30G1/2” or 32G
30G x 1/2”
30G x 1/2”
Teosyal ® products are non-permanent hyaluronic acid-based dermal llers. 1 - Glycine, Lysine, Threonine, Proline, lsoleucine, Leucine, Teosyal ® products are non-permanent hyaluronic acid-based dermal llers. 1 - Glycine, Lysine, Threonine, Proline, lsoleucine,
7
Made with FlippingBook interactive PDF creator